Anti-fibrotic actions of interleukin-10 against hypertrophic scarring by activation of PI3K/AKT and

来源 :全国第二十三届烧伤专业委员会学术会议 | 被引量 : 0次 | 上传用户:wangeryan8
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Background: The hypertrophic scar (HS) is a serious fibrotic skin condition and a major clinical problem.Interleukin-10 (IL-10) has been identified as a prospective scar-improving compound based on preclinical trials.
其他文献
  Hypertrophic scar, which is a troublesome problem in the field of tissue repairthat urgently need to be solved.Present study confirmed that TGF-β 1 induced
会议
  There were many ways to purificate recombinant Interleukin-10(IL-10) that aimimg to wound healing.However, therapeutic effect was not obvious.
会议
  Background: Although burn injury remains one of the most devastating ordeals for the human being, little has been reported on the individual patient's perce
会议
  Introduction Many burn injury patients, claiming the history of psychiatric disorders, do not meet sufficient mental health care.These problems are more ser
会议
  Hypertrophic scar (HS) is characterized by the overgrowth of fibroblasts and often considered as a kind of benign skin tumor, thus chemotherapeutic drugs ha
会议
  Autophagy, with the bulk degradation of proteins and organelles, is a process essential for cellular maintenance, cell viability, differentiation and develo
会议
  Hypertrophic scar (HS) is a serious skin fibrotic disease characterized by excessive hypercellularity proliferation and extracellular matrix (ECM) component
会议
  Hypertrophic scarring (HS) is a serious fibrotic skin condition, there is currently no satisfactory therapy to treat the disease, largely due to the undefin
会议
  The coxsackie and adenovirus receptor (CAR) is a cell adhesion molecule belonging to the immunoglobulin superfamily and is predominantly localized to cell-c
会议